M

Marmara University Medical Faculty | Pediatric Nephrology

Research site

(Unclaimed)

Location

Fevzi Cakmak Mahallesi, Muhsin Yazicioglu Caddesi N. 10 Pendik, Istanbul, Istanbul, Turkey

Site insights

Top conditions

Top treatments

Guselkumab

Macitentan

NNC0195-0092

Ziltivekimab

LY2835219

Somapacitan

Selexipag

Tadalafil

Abemaciclib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease (STAR)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Active, not recruiting

Arthritis, Psoriatic

Drug: Placebo

Drug: Guselkumab

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting

Crohn's Disease

Drug: Ustekinumab

Drug: Guselkumab Dose 3

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Active, not recruiting

Acute Myocardial Infarction (AMI)

Cardiovascular Risk

Drug: Ziltivekimab

Drug: Placebo

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension (UNISUS)

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Active, not recruiting

Pulmonary Arterial Hypertension

Drug: Placebo

Drug: Macitentan 75 mg